Liver function and drug processing: new study explores BI 1015550

NCT ID NCT05661344

First seen Jan 06, 2026 · Last updated May 24, 2026 · Updated 20 times

Summary

This study looked at how the drug BI 1015550 is processed in people with mild or moderate liver problems compared to those with healthy livers. Twenty-eight adults took a single dose of the drug, and researchers measured its levels in the blood over time. The goal was to understand if liver impairment changes how the drug behaves, which helps doctors decide on safe dosing. No treatment was given for any disease; this was purely to gather safety and processing information.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CRS Clinical Research Services Kiel GmbH

    Kiel, 24105, Germany

Conditions

Explore the condition pages connected to this study.